November 26, 2024
November 26, 2024
Categories

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

Do you like it?
Read more
November 25, 2024
November 25, 2024
Categories

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

Do you like it?
Read more
October 25, 2024
October 25, 2024
Categories

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

Do you like it?
Read more
October 15, 2024
October 15, 2024
Categories

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

Do you like it?
Read more
August 1, 2024
August 1, 2024
Categories

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

Do you like it?
Read more
November 15, 2023
November 15, 2023
Categories

Press Release: ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023

Do you like it?
Read more
April 6, 2023
April 6, 2023
Categories

E1411 study chair Mitchell Smith discusses the use of ibrutinib for patients with previously treated mantle cell lymphoma

Do you like it?
Read more
October 13, 2022
October 13, 2022
Categories

The September/October 2022 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group